VENLAFAXINE HYDROCHLORIDE

VENLAFAXINE HYDROCHLORIDE was reported 133443 times

VENLAFAXINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSPIRATORY CAPACITY DECREASED 105 0.3791
1 AMAUROSIS FUGAX 225 0.2089
2 TEMPERATURE REGULATION DISORDER 355 0.1592
3 RESPIRATORY DISORDER NEONATAL 230 0.1418
4 FEELINGS OF WORTHLESSNESS 184 0.1409
5 SELECTIVE EATING DISORDER 127 0.1396
6 HYPOTONIA NEONATAL 209 0.1337
7 SEROTONIN SYNDROME 2559 0.1331
8 AGITATION NEONATAL 115 0.1199
9 FEELING GUILTY 158 0.1197
10 PHYSICAL DECONDITIONING 305 0.1184
11 BRADYCARDIA NEONATAL 147 0.1169
12 CATAPLEXY 164 0.1157
13 MAJOR DEPRESSION 750 0.1025
14 ELECTRIC SHOCK SENSATION 264 0.0942
15 BEZOAR 113 0.0819
16 POISONING DELIBERATE 764 0.0805
17 FOETAL DEATH 413 0.0796
18 HYPERREFLEXIA 250 0.0717
19 EMOTIONAL POVERTY 114 0.0650
20 SLEEP PARALYSIS 95 0.0647
21 DEREALISATION 136 0.0632
22 HOSTILITY 155 0.0609
23 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 120 0.0607
24 PERSONALITY DISORDER 158 0.0603
25 CLONUS 165 0.0602
26 NEGATIVE THOUGHTS 173 0.0590
27 SMALL FOR DATES BABY 291 0.0586
28 FOOD ALLERGY 450 0.0582
29 HOMICIDAL IDEATION 236 0.0582
30 ANORGASMIA 158 0.0582
31 URINARY TRACT DISORDER 249 0.0552
32 SUICIDE ATTEMPT 3323 0.0548
33 HYPOMANIA 201 0.0546
34 MYDRIASIS 688 0.0536
35 WITHDRAWAL SYNDROME 2178 0.0518
36 GESTATIONAL DIABETES 247 0.0518
37 PSYCHOMOTOR RETARDATION 144 0.0512
38 TEARFULNESS 217 0.0504
39 ATRIAL SEPTAL DEFECT 420 0.0501
40 DECREASED INTEREST 295 0.0500
41 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 253 0.0493
42 ALCOHOL INTERACTION 95 0.0488
43 COMA SCALE ABNORMAL 140 0.0483
44 LIBIDO INCREASED 97 0.0478
45 NEONATAL RESPIRATORY DISTRESS SYNDROME 169 0.0477
46 DIABETIC NEUROPATHY 233 0.0470
47 PULMONARY PAIN 137 0.0469
48 SELF-INJURIOUS IDEATION 195 0.0464
49 SUICIDAL IDEATION 4247 0.0463
50 IMPULSIVE BEHAVIOUR 174 0.0463
51 INTENTIONAL OVERDOSE 2970 0.0463
52 COMPLETED SUICIDE 3814 0.0457
53 PSYCHOTIC SYMPTOM 94 0.0455
54 FLAT AFFECT 105 0.0453
55 BIPOLAR I DISORDER 99 0.0451
56 BLOOD PRESSURE SYSTOLIC ABNORMAL 111 0.0449
57 PATENT DUCTUS ARTERIOSUS 177 0.0445
58 PANIC DISORDER 172 0.0444
59 BIPOLAR DISORDER 482 0.0443
60 NIGHTMARE 1525 0.0440
61 SEDATION 1148 0.0438
62 STRESS CARDIOMYOPATHY 251 0.0431
63 DRUG SCREEN FALSE POSITIVE 119 0.0430
64 SUICIDAL BEHAVIOUR 176 0.0423
65 GAMBLING DISORDER 114 0.0422
66 BRUXISM 227 0.0421
67 LOGORRHOEA 148 0.0420
68 MANIA 684 0.0415
69 PERSECUTORY DELUSION 103 0.0413
70 PSYCHIATRIC SYMPTOM 303 0.0410
71 INTENTIONAL SELF-INJURY 824 0.0408
72 CRYING 1480 0.0407
73 BLOOD PRESSURE DIASTOLIC ABNORMAL 103 0.0405
74 DEPRESSIVE SYMPTOM 142 0.0402
75 PRE-EXISTING CONDITION IMPROVED 251 0.0402
76 DRUG WITHDRAWAL SYNDROME 3521 0.0401
77 APATHY 583 0.0399
78 DIABETIC COMA 111 0.0396
79 TALIPES 123 0.0396
80 TENSION 235 0.0385
81 TACHYPHRENIA 133 0.0384
82 SOPOR 506 0.0382
83 VENTRICULAR SEPTAL DEFECT 217 0.0379
84 SOCIAL AVOIDANT BEHAVIOUR 219 0.0378
85 COMA 1795 0.0377
86 MEDICATION RESIDUE 97 0.0376
87 SUSPECTED SUICIDE 174 0.0371
88 FEELING OF DESPAIR 173 0.0371
89 ALCOHOL POISONING 99 0.0369
90 ALCOHOL ABUSE 97 0.0362
91 HYPERACUSIS 135 0.0362
92 PRESCRIBED OVERDOSE 697 0.0360
93 MYOCLONUS 426 0.0357
94 HAEMORRHAGIC STROKE 277 0.0354
95 POST-TRAUMATIC STRESS DISORDER 237 0.0353
96 OBSESSIVE-COMPULSIVE DISORDER 281 0.0350
97 AKATHISIA 474 0.0347
98 ALTERED STATE OF CONSCIOUSNESS 750 0.0346
99 SOMNAMBULISM 227 0.0346
100 ENDOMETRIOSIS 164 0.0344
101 HALLUCINATIONS, MIXED 144 0.0342
102 DISSOCIATION 259 0.0338
103 SEXUAL DYSFUNCTION 394 0.0336
104 SINUS TACHYCARDIA 476 0.0335
105 ELECTROCARDIOGRAM QT PROLONGED 1195 0.0332
106 HALLUCINATION, AUDITORY 519 0.0326
107 CARDIOGENIC SHOCK 467 0.0325
108 SNORING 123 0.0325
109 MULTIPLE DRUG OVERDOSE INTENTIONAL 104 0.0323
110 COLITIS MICROSCOPIC 153 0.0323
111 NEUROLEPTIC MALIGNANT SYNDROME 382 0.0322
112 ENURESIS 130 0.0322
113 SELF INJURIOUS BEHAVIOUR 98 0.0321
114 DEPRESSION SUICIDAL 111 0.0320
115 IMMUNODEFICIENCY 477 0.0320
116 GENERALISED TONIC-CLONIC SEIZURE 525 0.0317
117 LOSS OF LIBIDO 284 0.0315
118 THINKING ABNORMAL 586 0.0314
119 CONGESTIVE CARDIOMYOPATHY 131 0.0314
120 COELIAC DISEASE 308 0.0314
121 PARKINSONISM 306 0.0314
122 RESTLESS LEGS SYNDROME 569 0.0313
123 TYPE 2 DIABETES MELLITUS 1045 0.0310
124 BURSITIS 376 0.0310
125 SLEEP APNOEA SYNDROME 587 0.0307
126 CONCUSSION 234 0.0302
127 POISONING 377 0.0300
128 DISTURBANCE IN ATTENTION 1615 0.0299
129 HEAD DISCOMFORT 530 0.0299
130 PARANOIA 516 0.0299
131 HYPERHIDROSIS 3855 0.0299
132 ANGER 1008 0.0298
133 PARADOXICAL DRUG REACTION 109 0.0296
134 ALCOHOLISM 126 0.0294
135 ANXIETY DISORDER 98 0.0293
136 POTENTIATING DRUG INTERACTION 98 0.0292
137 RESTLESSNESS 1067 0.0291
138 AGITATION 2141 0.0291
139 LEFT VENTRICULAR HYPERTROPHY 124 0.0289
140 PANIC ATTACK 1051 0.0288
141 HALLUCINATION, VISUAL 605 0.0286
142 PRE-ECLAMPSIA 136 0.0286
143 TOXICITY TO VARIOUS AGENTS 4808 0.0285
144 DEPRESSION 6387 0.0280
145 MUSCLE RIGIDITY 335 0.0280
146 DRUG INTERACTION 4441 0.0280
147 NYSTAGMUS 147 0.0277
148 PANIC REACTION 198 0.0274
149 ALCOHOL USE 101 0.0273
150 RESPIRATORY ACIDOSIS 107 0.0272
151 OBESITY 433 0.0272
152 DEPRESSED MOOD 1430 0.0270
153 HYPERLIPIDAEMIA 323 0.0270
154 DELUSION 418 0.0269
155 OCULAR DISCOMFORT 301 0.0268
156 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 275 0.0268
157 AFFECTIVE DISORDER 210 0.0267
158 EUPHORIC MOOD 273 0.0266
159 MUSCLE TWITCHING 609 0.0264
160 CARDIO-RESPIRATORY ARREST 1101 0.0263
161 CATATONIA 138 0.0263
162 LEFT VENTRICULAR DYSFUNCTION 176 0.0262
163 RESPIRATORY DEPRESSION 321 0.0262
164 NEPHROGENIC ANAEMIA 121 0.0261
165 HYPERTONIA 149 0.0260
166 FULL BLOOD COUNT ABNORMAL 275 0.0260
167 APPETITE DISORDER 172 0.0259
168 MIOSIS 208 0.0259
169 PSYCHOMOTOR HYPERACTIVITY 425 0.0256
170 METABOLIC ACIDOSIS 817 0.0255
171 TYPE 1 DIABETES MELLITUS 153 0.0254
172 ABNORMAL DREAMS 701 0.0254
173 PSYCHOLOGICAL TRAUMA 218 0.0252
174 PERSONALITY CHANGE 233 0.0251
175 PHOTOPHOBIA 470 0.0250
176 COORDINATION ABNORMAL 348 0.0249
177 IMPAIRED WORK ABILITY 532 0.0249
178 FEELING DRUNK 183 0.0246
179 CARDIOTOXICITY 219 0.0245
180 SLEEP TERROR 103 0.0244
181 TINNITUS 1116 0.0243
182 DRUG SCREEN POSITIVE 191 0.0241
183 ACTIVITIES OF DAILY LIVING IMPAIRED 473 0.0239
184 SPINAL OSTEOARTHRITIS 208 0.0237
185 GLUCOSE TOLERANCE IMPAIRED 140 0.0236
186 IMPAIRED DRIVING ABILITY 269 0.0236
187 DRUG ABUSE 1969 0.0236
188 MULTIPLE DRUG OVERDOSE 117 0.0236
189 INTERVERTEBRAL DISC DEGENERATION 217 0.0234
190 DRUG USE DISORDER 197 0.0234
191 BLOOD PRESSURE DIASTOLIC INCREASED 108 0.0234
192 BRADYPHRENIA 152 0.0232
193 VISUAL DISTURBANCE 133 0.0232
194 IRRITABILITY 1390 0.0231
195 DYSPHEMIA 101 0.0230
196 AFFECT LABILITY 221 0.0229
197 AGGRESSION 1146 0.0229
198 MENTAL IMPAIRMENT 555 0.0229
199 PULSELESS ELECTRICAL ACTIVITY 95 0.0227
200 HYPERTHERMIA 173 0.0226
201 BUNDLE BRANCH BLOCK RIGHT 104 0.0226
202 ORTHOSTATIC HYPOTENSION 394 0.0226
203 GENERALISED OEDEMA 280 0.0226
204 INCOHERENT 146 0.0225
205 PSYCHOTIC DISORDER 662 0.0224
206 GRAND MAL CONVULSION 205 0.0222
207 DYSPHORIA 112 0.0221
208 CARDIOMEGALY 272 0.0221
209 EYE MOVEMENT DISORDER 151 0.0220
210 DISORIENTATION 872 0.0220
211 ANXIETY 6242 0.0219
212 DRUG EXPOSURE DURING PREGNANCY 746 0.0219
213 URINARY INCONTINENCE 644 0.0217
214 VENTRICULAR TACHYCARDIA 358 0.0217
215 EMOTIONAL DISORDER 668 0.0216
216 MENTAL DISORDER 927 0.0213
217 PRODUCT ADMINISTRATION INTERRUPTED 167 0.0213
218 MITRAL VALVE INCOMPETENCE 239 0.0211
219 DRUG LEVEL ABOVE THERAPEUTIC 96 0.0209
220 MOOD SWINGS 668 0.0209
221 TREMOR 3471 0.0209
222 BLOOD TRIGLYCERIDES INCREASED 369 0.0209
223 BRADYKINESIA 123 0.0208
224 FAECAL INCONTINENCE 100 0.0208
225 TRICUSPID VALVE INCOMPETENCE 165 0.0207
226 DYSLIPIDAEMIA 105 0.0207
227 HYPERNATRAEMIA 103 0.0206
228 DRUG WITHDRAWAL SYNDROME NEONATAL 306 0.0206
229 HYPOTHERMIA 209 0.0206
230 DIPLOPIA 535 0.0206
231 DYSKINESIA 837 0.0206
232 DEPRESSED LEVEL OF CONSCIOUSNESS 814 0.0206
233 TACHYCARDIA 1827 0.0205
234 INCONTINENCE 217 0.0205
235 HYPERSOMNIA 588 0.0205
236 NONSPECIFIC REACTION 112 0.0204
237 FOOD CRAVING 107 0.0203
238 SUBSTANCE ABUSE 165 0.0203
239 AMNESIA 1318 0.0202
240 GALACTORRHOEA 130 0.0202
241 ERECTILE DYSFUNCTION 517 0.0201
242 FEELING OF BODY TEMPERATURE CHANGE 118 0.0201
243 FOETAL EXPOSURE DURING PREGNANCY 1636 0.0201
244 MATERNAL DRUGS AFFECTING FOETUS 154 0.0201
245 ARTERIOSCLEROSIS CORONARY ARTERY 133 0.0201
246 CHOLECYSTITIS CHRONIC 134 0.0200
247 BODY TEMPERATURE DECREASED 197 0.0200
248 HYPERTRIGLYCERIDAEMIA 117 0.0200
249 ABNORMAL BEHAVIOUR 791 0.0199
250 POOR QUALITY SLEEP 429 0.0199
251 HAIR DISORDER 164 0.0199
252 DRUG LEVEL INCREASED 329 0.0199
253 CEREBRAL DISORDER 147 0.0199
254 DIABETES MELLITUS 1513 0.0198
255 NERVOUSNESS 1037 0.0198
256 HYPERVENTILATION 115 0.0198
257 FIBROMYALGIA 481 0.0198
258 BRONCHIECTASIS 133 0.0197
259 SOMNOLENCE 3955 0.0196
260 ATELECTASIS 189 0.0195
261 FEAR 524 0.0195
262 HYPONATRAEMIA 1097 0.0195
263 MIDDLE INSOMNIA 362 0.0194
264 BLOOD LACTIC ACID INCREASED 102 0.0193
265 FEELING JITTERY 369 0.0193
266 PNEUMONIA ASPIRATION 483 0.0193
267 MICTURITION URGENCY 220 0.0192
268 BLOOD PRESSURE SYSTOLIC INCREASED 375 0.0192
269 INTESTINAL ISCHAEMIA 105 0.0190
270 VERTIGO 1161 0.0190
271 LIGAMENT SPRAIN 188 0.0190
272 TRISMUS 98 0.0190
273 ANAL INCONTINENCE 169 0.0188
274 COGNITIVE DISORDER 877 0.0188
275 CONFUSIONAL STATE 3032 0.0187
276 PRESYNCOPE 456 0.0187
277 BRAIN INJURY 188 0.0187
278 HYPERPROLACTINAEMIA 121 0.0186
279 BLOOD CHOLESTEROL INCREASED 866 0.0186
280 DRUG TOXICITY 251 0.0184
281 INSOMNIA 4906 0.0184
282 TORSADE DE POINTES 144 0.0183
283 RIB FRACTURE 377 0.0183
284 ENERGY INCREASED 108 0.0183
285 ECONOMIC PROBLEM 277 0.0183
286 HAEMATEMESIS 463 0.0182
287 ACUTE RESPIRATORY DISTRESS SYNDROME 323 0.0182
288 FAECALOMA 100 0.0182
289 EXTRAPYRAMIDAL DISORDER 451 0.0181
290 OVERWEIGHT 97 0.0180
291 ACIDOSIS 138 0.0180
292 NIGHT SWEATS 581 0.0180
293 SENSORY DISTURBANCE 289 0.0180
294 ASPIRATION 197 0.0180
295 BEHAVIOUR DISORDER 97 0.0179
296 HYPOTONIA 179 0.0179
297 METABOLIC DISORDER 104 0.0179
298 NEPHROLITHIASIS 821 0.0179
299 HEPATIC STEATOSIS 332 0.0178
300 MIGRAINE 1699 0.0178
301 DELIRIUM 617 0.0178
302 CONVULSION 1016 0.0177
303 INTERVERTEBRAL DISC PROTRUSION 387 0.0177
304 NEUROLOGICAL SYMPTOM 101 0.0177
305 CARPAL TUNNEL SYNDROME 247 0.0176
306 HEPATOCELLULAR INJURY 250 0.0176
307 ELECTROCARDIOGRAM ABNORMAL 138 0.0176
308 ANURIA 151 0.0175
309 MOOD ALTERED 474 0.0174
310 ANAL FISSURE 93 0.0173
311 DYSARTHRIA 652 0.0173
312 BLOOD PRESSURE DIASTOLIC DECREASED 127 0.0172
313 SCHIZOPHRENIA 208 0.0171
314 SALIVARY HYPERSECRETION 171 0.0171
315 URINARY RETENTION 570 0.0171
316 CARDIOMYOPATHY 252 0.0170
317 PARAESTHESIA 2678 0.0170
318 EXPOSURE DURING PREGNANCY 1057 0.0170
319 SWOLLEN TONGUE 531 0.0170
320 FOETAL GROWTH RESTRICTION 103 0.0169
321 ANKLE FRACTURE 261 0.0168
322 STATUS EPILEPTICUS 190 0.0168
323 ENCEPHALOPATHY 413 0.0168
324 ANHEDONIA 441 0.0168
325 HYPOKINESIA 242 0.0167
326 HALLUCINATION 1255 0.0166
327 BALANCE DISORDER 1439 0.0166
328 OBSTRUCTIVE AIRWAYS DISORDER 185 0.0166
329 RESPIRATORY ARREST 458 0.0166
330 COLITIS ISCHAEMIC 112 0.0166
331 HYPOVOLAEMIA 97 0.0166
332 INITIAL INSOMNIA 170 0.0166
333 EXOSTOSIS 151 0.0165
334 SCREAMING 105 0.0165
335 HYPERCHOLESTEROLAEMIA 159 0.0165
336 DENTAL CARIES 182 0.0164
337 HIATUS HERNIA 213 0.0164
338 SLEEP DISORDER 1160 0.0164
339 ATAXIA 195 0.0164
340 FEELING ABNORMAL 3936 0.0164
341 ASPHYXIA 134 0.0164
342 FORMICATION 114 0.0164
343 NERVOUS SYSTEM DISORDER 511 0.0164
344 DRUG INTOLERANCE 1566 0.0162
345 VITAMIN D DEFICIENCY 158 0.0162
346 HAEMODYNAMIC INSTABILITY 123 0.0161
347 BEDRIDDEN 212 0.0161
348 WEIGHT INCREASED 3605 0.0161
349 INTENTIONAL DRUG MISUSE 336 0.0161
350 RHABDOMYOLYSIS 669 0.0160
351 SCOLIOSIS 99 0.0160
352 OVERDOSE 3445 0.0160
353 HOT FLUSH 1196 0.0159
354 PHOTOPSIA 100 0.0158
355 HEAD INJURY 499 0.0158
356 VENTRICULAR FIBRILLATION 175 0.0157
357 HAIR COLOUR CHANGES 195 0.0157
358 MENTAL STATUS CHANGES 435 0.0156
359 SENSORY LOSS 126 0.0156
360 APHTHOUS ULCER 121 0.0156
361 FACIAL PAIN 139 0.0156
362 INTENTIONAL PRODUCT MISUSE 1357 0.0155
363 UNRESPONSIVE TO STIMULI 399 0.0154
364 TARDIVE DYSKINESIA 436 0.0154
365 DIABETES MELLITUS INADEQUATE CONTROL 273 0.0154
366 IMPAIRED QUALITY OF LIFE 221 0.0154
367 SPEECH DISORDER 803 0.0153
368 MUSCLE TIGHTNESS 248 0.0153
369 HYPERGLYCAEMIA 557 0.0153
370 DRY MOUTH 1239 0.0153
371 CIRCULATORY COLLAPSE 260 0.0153
372 HAIR TEXTURE ABNORMAL 203 0.0152
373 INCREASED APPETITE 289 0.0151
374 VENTRICULAR EXTRASYSTOLES 156 0.0150
375 RETCHING 320 0.0150
376 BODY TEMPERATURE INCREASED 306 0.0150
377 RESPIRATORY RATE INCREASED 133 0.0150
378 UPPER RESPIRATORY TRACT INFECTION 690 0.0149
379 FOOT FRACTURE 283 0.0149
380 LACTIC ACIDOSIS 483 0.0149
381 HYPERTENSION 3153 0.0149
382 CARDIAC FAILURE ACUTE 99 0.0148
383 EJECTION FRACTION DECREASED 231 0.0148
384 EAR PAIN 287 0.0147
385 MEMORY IMPAIRMENT 2018 0.0147
386 SCIATICA 234 0.0147
387 INCREASED TENDENCY TO BRUISE 135 0.0147
388 LETHARGY 844 0.0147
389 DIZZINESS POSTURAL 142 0.0146
390 FRUSTRATION TOLERANCE DECREASED 118 0.0146
391 CONTRAINDICATED PRODUCT ADMINISTERED 442 0.0146
392 IMPAIRED GASTRIC EMPTYING 199 0.0146
393 BACK INJURY 158 0.0145
394 TOOTH FRACTURE 160 0.0145
395 FALL 4809 0.0144
396 CARDIAC ARREST 1190 0.0144
397 MUSCULOSKELETAL CHEST PAIN 223 0.0144
398 MOVEMENT DISORDER 461 0.0143
399 LACERATION 135 0.0143
400 EATING DISORDER 305 0.0143
401 BLOOD PRESSURE INCREASED 2187 0.0143
402 MADAROSIS 166 0.0143
403 SEIZURE 1648 0.0143
404 BRAIN FOG 223 0.0142
405 CARDIAC MURMUR 123 0.0142
406 CHRONIC KIDNEY DISEASE 1079 0.0142
407 ANOREXIA 183 0.0142
408 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 779 0.0142
409 OSTEOARTHRITIS 601 0.0142
410 GASTROOESOPHAGEAL REFLUX DISEASE 1141 0.0142
411 HYPOGLYCAEMIA 687 0.0141
412 LOSS OF CONSCIOUSNESS 1810 0.0141
413 IRON DEFICIENCY ANAEMIA 130 0.0141
414 EXTRASYSTOLES 98 0.0140
415 PULMONARY CONGESTION 185 0.0140
416 HYPERAESTHESIA 115 0.0140
417 RESPIRATORY DISTRESS 386 0.0140
418 HAND FRACTURE 99 0.0140
419 HEPATIC CYTOLYSIS 178 0.0139
420 TONGUE DISORDER 101 0.0139
421 TOOTH ABSCESS 142 0.0139
422 DYSSTASIA 406 0.0139
423 MOUTH ULCERATION 292 0.0138
424 HEPATIC ENZYME INCREASED 944 0.0138
425 ROAD TRAFFIC ACCIDENT 578 0.0138
426 TROPONIN INCREASED 105 0.0138
427 ASTHMA 1558 0.0138
428 PRODUCT SUBSTITUTION ISSUE 793 0.0138
429 APHASIA 414 0.0137
430 PANCREATITIS 720 0.0136
431 THIRST 243 0.0136
432 BLOOD PRESSURE FLUCTUATION 326 0.0136
433 NERVE INJURY 151 0.0136
434 VITAMIN D DECREASED 116 0.0136
435 HYPOTHYROIDISM 433 0.0135
436 BLOOD CREATINE PHOSPHOKINASE INCREASED 389 0.0135
437 COLD SWEAT 238 0.0135
438 NEURALGIA 327 0.0134
439 QUALITY OF LIFE DECREASED 180 0.0134
440 IRRITABLE BOWEL SYNDROME 287 0.0134
441 DIZZINESS 6665 0.0133
442 MUSCLE SPASTICITY 164 0.0133
443 HEART RATE INCREASED 1322 0.0133
444 JOINT DISLOCATION 141 0.0133
445 BONE DISORDER 243 0.0133
446 OSTEOPENIA 202 0.0133
447 CONGENITAL ANOMALY 103 0.0133
448 RASH ERYTHEMATOUS 635 0.0133
449 ARTERIOSCLEROSIS 125 0.0133
450 GALLBLADDER DISORDER 237 0.0133
451 EPILEPSY 405 0.0132
452 CAESAREAN SECTION 154 0.0132
453 PREMATURE BABY 397 0.0132
454 HEART RATE IRREGULAR 298 0.0132
455 ACUTE KIDNEY INJURY 2013 0.0131
456 SLUGGISHNESS 133 0.0130
457 ROTATOR CUFF SYNDROME 167 0.0130
458 NERVE COMPRESSION 119 0.0129
459 NEUTROPHIL COUNT INCREASED 132 0.0129
460 NECK PAIN 720 0.0129
461 PALPITATIONS 1508 0.0129
462 HAEMORRHOIDS 251 0.0129
463 TENDERNESS 134 0.0128
464 PYELONEPHRITIS 111 0.0128
465 BACK DISORDER 208 0.0128
466 WRIST FRACTURE 153 0.0128
467 PERIPHERAL COLDNESS 175 0.0127
468 MUSCLE DISORDER 103 0.0127
469 TEMPERATURE INTOLERANCE 131 0.0127
470 CHOLESTASIS 243 0.0126
471 SKIN LACERATION 137 0.0126
472 RENAL CYST 100 0.0126
473 GASTRITIS 330 0.0125
474 SINUS BRADYCARDIA 121 0.0125
475 PANCREATITIS ACUTE 281 0.0125
476 DYSURIA 458 0.0124
477 SCAR 213 0.0124
478 ASCITES 364 0.0124
479 PHOTOSENSITIVITY REACTION 204 0.0123
480 HYPERTENSIVE CRISIS 137 0.0123
481 CHOLELITHIASIS 403 0.0123
482 CONSTIPATION 2675 0.0123
483 OXYGEN SATURATION DECREASED 686 0.0122
484 EMPHYSEMA 123 0.0122
485 POOR VENOUS ACCESS 126 0.0122
486 CONDITION AGGRAVATED 3692 0.0121
487 SYNCOPE 1212 0.0121
488 HEADACHE 7587 0.0121
489 SUDDEN DEATH 128 0.0121
490 INFUSION RELATED REACTION 799 0.0120
491 VISION BLURRED 1651 0.0120
492 THYROID DISORDER 184 0.0119
493 BRONCHITIS 883 0.0119
494 DYSPHONIA 697 0.0119
495 ANKYLOSING SPONDYLITIS 157 0.0119
496 CYSTITIS 379 0.0119
497 EAR DISCOMFORT 122 0.0119
498 FLANK PAIN 111 0.0118
499 SUBARACHNOID HAEMORRHAGE 120 0.0118
500 HUNGER 164 0.0118
501 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 104 0.0118
502 SHOCK 270 0.0117
503 THERAPEUTIC RESPONSE UNEXPECTED 526 0.0117
504 RENAL TUBULAR NECROSIS 115 0.0117
505 SPUTUM DISCOLOURED 111 0.0117
506 DYSTONIA 227 0.0117
507 NAUSEA 9261 0.0117
508 ORAL PAIN 262 0.0117
509 MOTOR DYSFUNCTION 119 0.0117
510 HYPOAESTHESIA 1743 0.0116
511 UPPER LIMB FRACTURE 232 0.0116
512 HYPOMAGNESAEMIA 162 0.0116
513 BODY HEIGHT DECREASED 124 0.0116
514 HAEMATURIA 397 0.0116
515 BLADDER DISORDER 115 0.0116
516 GASTROENTERITIS 169 0.0116
517 ANGIOEDEMA 512 0.0116
518 BLOOD SODIUM DECREASED 218 0.0116
519 LUNG INFILTRATION 102 0.0115
520 BLOOD POTASSIUM DECREASED 347 0.0115
521 CLOSTRIDIUM DIFFICILE COLITIS 122 0.0115
522 HYPOKALAEMIA 530 0.0115
523 NOCTURIA 139 0.0114
524 DECREASED IMMUNE RESPONSIVENESS 112 0.0114
525 SPINAL COMPRESSION FRACTURE 94 0.0114
526 MALNUTRITION 127 0.0113
527 CONTUSION 1088 0.0113
528 CYST 140 0.0113
529 HEART RATE DECREASED 396 0.0113
530 TACHYPNOEA 153 0.0112
531 LIVER FUNCTION TEST ABNORMAL 327 0.0112
532 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 540 0.0112
533 END STAGE RENAL DISEASE 205 0.0112
534 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 586 0.0112
535 SUPRAVENTRICULAR TACHYCARDIA 107 0.0112
536 HYPOTENSION 2220 0.0111
537 FEELING COLD 308 0.0111
538 FEELING HOT 678 0.0110
539 GAMMA-GLUTAMYLTRANSFERASE INCREASED 245 0.0110
540 JOINT INJURY 236 0.0110
541 ABDOMINAL PAIN 2561 0.0110
542 MUSCLE STRAIN 95 0.0110
543 GAIT DISTURBANCE 2099 0.0110
544 BRADYCARDIA 581 0.0109
545 MASS 153 0.0109
546 HEPATIC ENCEPHALOPATHY 102 0.0109
547 BLINDNESS 445 0.0109
548 OSTEOPOROSIS 449 0.0109
549 CHOLECYSTITIS 130 0.0109
550 WEIGHT FLUCTUATION 114 0.0109
551 PHARYNGITIS 135 0.0109
552 SWELLING FACE 707 0.0108
553 BRAIN OEDEMA 137 0.0108
554 HYPOPHAGIA 277 0.0108
555 ARRHYTHMIA 513 0.0108
556 FOOT DEFORMITY 120 0.0108
557 INFLUENZA LIKE ILLNESS 891 0.0108
558 MYALGIA 1837 0.0108
559 CHILLS 1266 0.0108
560 FLUID RETENTION 549 0.0108
561 MUSCULOSKELETAL STIFFNESS 945 0.0108
562 TOOTHACHE 195 0.0108
563 WEIGHT DECREASED 2997 0.0107
564 ORAL CANDIDIASIS 141 0.0107
565 DEHYDRATION 1426 0.0107
566 EYE PAIN 602 0.0107
567 FATIGUE 8305 0.0107
568 PULMONARY EMBOLISM 1011 0.0106
569 CENTRAL NERVOUS SYSTEM LESION 146 0.0106
570 VOMITING 4993 0.0106
571 DRUG EFFECT DECREASED 572 0.0106
572 ASTHENIA 3982 0.0106
573 LEUKOCYTOSIS 191 0.0105
574 BLOOD ALKALINE PHOSPHATASE INCREASED 261 0.0105
575 DECREASED ACTIVITY 113 0.0105
576 SEASONAL ALLERGY 148 0.0104
577 WHITE BLOOD CELL COUNT INCREASED 401 0.0104
578 MULTIPLE ORGAN DYSFUNCTION SYNDROME 296 0.0104
579 DYSPEPSIA 1028 0.0104
580 OSTEOMYELITIS 189 0.0104
581 CORONARY ARTERY OCCLUSION 143 0.0104
582 DISABILITY 206 0.0104
583 MALAISE 4568 0.0104
584 DRUG LEVEL DECREASED 106 0.0104
585 SUBDURAL HAEMATOMA 149 0.0104
586 LYMPHOCYTE COUNT DECREASED 183 0.0103
587 SKIN INFECTION 116 0.0103
588 MUSCULAR WEAKNESS 1175 0.0103
589 ARTHRITIS 812 0.0103
590 FISTULA 116 0.0103
591 GASTROINTESTINAL PAIN 113 0.0103
592 SPINAL DISORDER 97 0.0102
593 TRANSIENT ISCHAEMIC ATTACK 345 0.0102
594 BLOOD PRESSURE ABNORMAL 203 0.0102
595 OVARIAN CYST 102 0.0102
596 LOWER RESPIRATORY TRACT INFECTION 464 0.0102
597 BACK PAIN 2364 0.0102
598 CYANOSIS 160 0.0102
599 HYPOXIA 357 0.0101
600 ACUTE RESPIRATORY FAILURE 195 0.0101
601 RECTAL HAEMORRHAGE 434 0.0101
602 DYSPHAGIA 958 0.0101
603 DIABETIC KETOACIDOSIS 242 0.0101
604 TOOTH DISORDER 224 0.0101
605 ELECTROLYTE IMBALANCE 117 0.0101
606 CHEST PAIN 1864 0.0101
607 MULTIPLE SCLEROSIS 481 0.0100
608 LIMB DISCOMFORT 311 0.0100
609 STAPHYLOCOCCAL INFECTION 331 0.0100
610 ACUTE HEPATIC FAILURE 137 0.0100
611 URINARY TRACT INFECTION 1708 0.0100
612 TOOTH INFECTION 132 0.0100
613 DECREASED APPETITE 2323 0.0100
614 PAIN IN JAW 283 0.0100
615 ACCIDENT 119 0.0100
616 TREATMENT NONCOMPLIANCE 544 0.0099
617 SINUSITIS 1019 0.0099
618 HAEMATOCRIT DECREASED 197 0.0099
619 MUSCULOSKELETAL PAIN 519 0.0099
620 POLLAKIURIA 412 0.0099
621 RENAL FAILURE 1309 0.0098
622 CELLULITIS 496 0.0098
623 ACCIDENTAL OVERDOSE 360 0.0098
624 LIMB INJURY 267 0.0098
625 EOSINOPHILIA 172 0.0098
626 PULMONARY MASS 146 0.0098
627 OESOPHAGITIS 107 0.0098
628 MUSCLE SPASMS 1797 0.0098
629 HEPATOMEGALY 96 0.0098
630 UNEVALUABLE EVENT 739 0.0098
631 KNEE ARTHROPLASTY 205 0.0097
632 ARTHROPATHY 541 0.0097
633 PULMONARY THROMBOSIS 106 0.0097
634 JOINT SWELLING 1173 0.0097
635 MEDICATION ERROR 540 0.0097
636 MYOCARDITIS 111 0.0097
637 HEPATIC CIRRHOSIS 180 0.0096
638 SCRATCH 101 0.0096
639 RENAL FAILURE ACUTE 405 0.0095
640 BLOOD IRON DECREASED 113 0.0095
641 PARAESTHESIA ORAL 137 0.0095
642 GASTROENTERITIS VIRAL 171 0.0095
643 ABASIA 234 0.0095
644 INTENTIONAL PRODUCT USE ISSUE 827 0.0094
645 INJURY 663 0.0094
646 ABSCESS 150 0.0094
647 DYSPNOEA EXERTIONAL 353 0.0094
648 CHOLECYSTECTOMY 107 0.0094
649 MUSCULOSKELETAL DISCOMFORT 161 0.0093
650 JOINT STIFFNESS 245 0.0093
651 CHOKING 181 0.0093
652 THERAPY NON-RESPONDER 417 0.0093
653 DRUG-INDUCED LIVER INJURY 290 0.0092
654 ASPARTATE AMINOTRANSFERASE INCREASED 490 0.0092
655 BACTERIAL INFECTION 172 0.0092
656 PAIN 5632 0.0092
657 TREATMENT FAILURE 759 0.0092
658 ABDOMINAL DISCOMFORT 1536 0.0091
659 HYPOAESTHESIA ORAL 138 0.0091
660 HEMIPARESIS 155 0.0091
661 CORONARY ARTERY DISEASE 277 0.0091
662 DEEP VEIN THROMBOSIS 593 0.0091
663 DEMENTIA 255 0.0091
664 SECRETION DISCHARGE 114 0.0091
665 ABDOMINAL PAIN LOWER 230 0.0091
666 PULMONARY OEDEMA 406 0.0091
667 EAR INFECTION 239 0.0090
668 ABDOMINAL PAIN UPPER 1849 0.0090
669 PRODUCTIVE COUGH 428 0.0090
670 MYOCARDIAL ISCHAEMIA 102 0.0090
671 MATERNAL EXPOSURE DURING PREGNANCY 796 0.0089
672 RHEUMATOID ARTHRITIS 1011 0.0089
673 OEDEMA PERIPHERAL 1082 0.0089
674 ALANINE AMINOTRANSFERASE INCREASED 545 0.0089
675 PULMONARY HYPERTENSION 184 0.0088
676 ABNORMAL WEIGHT GAIN 109 0.0088
677 PARALYSIS 126 0.0088
678 LOWER LIMB FRACTURE 169 0.0088
679 HAEMATOCHEZIA 485 0.0088
680 AMENORRHOEA 154 0.0088
681 ANGINA PECTORIS 251 0.0088
682 SINUS CONGESTION 118 0.0087
683 PRODUCT PRESCRIBING ERROR 208 0.0087
684 LYMPHADENOPATHY 309 0.0087
685 ARTHRALGIA 3629 0.0087
686 BREAST PAIN 93 0.0087
687 AGRANULOCYTOSIS 162 0.0087
688 INTESTINAL OBSTRUCTION 328 0.0087
689 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 149 0.0087
690 EYELID OEDEMA 101 0.0087
691 SPINAL FRACTURE 174 0.0087
692 SKIN LESION 238 0.0087
693 HYPERSENSITIVITY 1610 0.0087
694 HYPERKALAEMIA 303 0.0086
695 GENERAL PHYSICAL HEALTH DETERIORATION 997 0.0086
696 ILEUS 107 0.0086
697 FEEDING DISORDER 174 0.0086
698 OROPHARYNGEAL PAIN 792 0.0085
699 PLATELET COUNT INCREASED 111 0.0085
700 TENDON RUPTURE 105 0.0085
701 TRANSAMINASES INCREASED 189 0.0085
702 BLOOD PRESSURE DECREASED 564 0.0085
703 NASAL CONGESTION 498 0.0085
704 GLAUCOMA 163 0.0085
705 TENDONITIS 131 0.0085
706 VISUAL IMPAIRMENT 1041 0.0084
707 INFLAMMATION 433 0.0084
708 FLATULENCE 475 0.0084
709 ORAL HERPES 163 0.0083
710 CANDIDA INFECTION 141 0.0083
711 NEUROPATHY PERIPHERAL 794 0.0083
712 WHEEZING 493 0.0083
713 ABDOMINAL DISTENSION 867 0.0083
714 FAECES DISCOLOURED 180 0.0083
715 MOBILITY DECREASED 596 0.0083
716 RED BLOOD CELL COUNT DECREASED 237 0.0083
717 BURNING SENSATION 581 0.0083
718 PAIN IN EXTREMITY 2441 0.0083
719 DIARRHOEA 5345 0.0083
720 PSORIASIS 1081 0.0083
721 KIDNEY INFECTION 162 0.0082
722 CHROMATURIA 186 0.0082
723 WRONG TECHNIQUE IN DRUG USAGE PROCESS 299 0.0082
724 COAGULOPATHY 137 0.0082
725 SMALL INTESTINAL OBSTRUCTION 101 0.0082
726 MENORRHAGIA 161 0.0082
727 THROMBOCYTOPENIA 915 0.0082
728 DYSPNOEA 4624 0.0082
729 ULCER 129 0.0081
730 DERMATITIS ALLERGIC 102 0.0081
731 POLYNEUROPATHY 97 0.0081
732 PRODUCT USE IN UNAPPROVED INDICATION 2003 0.0081
733 MULTIPLE SCLEROSIS RELAPSE 553 0.0081
734 CLOSTRIDIUM DIFFICILE INFECTION 176 0.0081
735 FREQUENT BOWEL MOVEMENTS 217 0.0080
736 HYPOCALCAEMIA 152 0.0080
737 HYPERTHYROIDISM 116 0.0080
738 INFLUENZA 891 0.0080
739 GAIT INABILITY 267 0.0080
740 SINUS DISORDER 158 0.0080
741 C-REACTIVE PROTEIN INCREASED 290 0.0080
742 IMMUNE SYSTEM DISORDER 105 0.0080
743 COUGH 2233 0.0080
744 DISCOMFORT 484 0.0079
745 DRUG DEPENDENCE 1275 0.0079
746 PYREXIA 2742 0.0079
747 HAEMATOMA 205 0.0079
748 FUNGAL INFECTION 263 0.0079
749 PREGNANCY 158 0.0079
750 ALOPECIA 1548 0.0079
751 SPINAL OPERATION 97 0.0079
752 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 558 0.0078
753 GASTRIC ULCER 149 0.0078
754 FACE OEDEMA 132 0.0078
755 SEPSIS 871 0.0078
756 DYSGEUSIA 580 0.0078
757 WOUND 218 0.0078
758 DRUG EFFECT INCOMPLETE 283 0.0078
759 TUBULOINTERSTITIAL NEPHRITIS 146 0.0078
760 POST PROCEDURAL COMPLICATION 149 0.0078
761 HEPATITIS 198 0.0077
762 MUSCLE ATROPHY 98 0.0077
763 GLOMERULAR FILTRATION RATE DECREASED 95 0.0077
764 DRUG INEFFECTIVE 10188 0.0077
765 PRODUCT ADMINISTRATION ERROR 156 0.0077
766 CARDIAC FAILURE CONGESTIVE 620 0.0077
767 TOOTH EXTRACTION 96 0.0077
768 MUSCULOSKELETAL DISORDER 146 0.0077
769 FLUSHING 779 0.0077
770 TOOTH LOSS 158 0.0076
771 PULMONARY FIBROSIS 146 0.0076
772 DEAFNESS 199 0.0076
773 RESPIRATORY FAILURE 554 0.0076
774 PELVIC PAIN 138 0.0076
775 HEPATOTOXICITY 169 0.0076
776 BLOOD COUNT ABNORMAL 115 0.0076
777 SKIN ULCER 196 0.0076
778 LYMPHOPENIA 107 0.0076
779 DRY EYE 377 0.0075
780 THERAPY CESSATION 386 0.0075
781 VIRAL INFECTION 250 0.0075
782 BONE PAIN 440 0.0075
783 HERNIA 145 0.0075
784 COLITIS 283 0.0075
785 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 192 0.0075
786 CATARACT 444 0.0074
787 METASTASES TO LIVER 131 0.0074
788 EYE DISORDER 245 0.0074
789 BASAL CELL CARCINOMA 116 0.0074
790 HERPES ZOSTER 427 0.0074
791 GASTRIC DISORDER 255 0.0074
792 RHINORRHOEA 480 0.0074
793 GASTROINTESTINAL DISORDER 664 0.0074
794 INTERNATIONAL NORMALISED RATIO INCREASED 211 0.0074
795 DIVERTICULITIS 205 0.0074
796 GINGIVAL BLEEDING 101 0.0074
797 PRODUCT USE ISSUE 1388 0.0074
798 RENAL INJURY 218 0.0073
799 EMOTIONAL DISTRESS 886 0.0073
800 PERIPHERAL SWELLING 1126 0.0073
801 IMPAIRED HEALING 239 0.0073
802 NODULE 95 0.0073
803 LOCALISED INFECTION 176 0.0073
804 NASOPHARYNGITIS 1340 0.0073
805 BLOOD URINE PRESENT 138 0.0073
806 PHARYNGEAL OEDEMA 111 0.0072
807 PALLOR 196 0.0072
808 CARDIAC FAILURE 577 0.0072
809 OFF LABEL USE 6269 0.0072
810 LEUKOPENIA 358 0.0071
811 LUNG INFECTION 111 0.0071
812 PRURITUS GENERALISED 154 0.0071
813 SKIN DISORDER 237 0.0071
814 RASH MACULO-PAPULAR 158 0.0071
815 APHONIA 99 0.0071
816 HIP FRACTURE 228 0.0071
817 PNEUMONIA 2291 0.0071
818 OSTEONECROSIS OF JAW 175 0.0071
819 CHEST DISCOMFORT 724 0.0071
820 ABORTION SPONTANEOUS 283 0.0071
821 LOCAL SWELLING 123 0.0070
822 OEDEMA 381 0.0070
823 THROAT TIGHTNESS 190 0.0070
824 GOUT 126 0.0070
825 ANAEMIA 1336 0.0070
826 SURGERY 410 0.0070
827 RESPIRATORY TRACT INFECTION 182 0.0070
828 AGEUSIA 172 0.0069
829 LIVER INJURY 169 0.0069
830 HEPATIC FAILURE 207 0.0069
831 INFECTION 990 0.0068
832 ATRIAL FIBRILLATION 665 0.0068
833 DISEASE RECURRENCE 323 0.0068
834 GLOSSODYNIA 152 0.0068
835 FRACTURE 128 0.0068
836 PRURITUS 2584 0.0067
837 MUCOSAL INFLAMMATION 176 0.0067
838 ERUCTATION 130 0.0067
839 RESPIRATORY DISORDER 201 0.0067
840 DRUG PRESCRIBING ERROR 129 0.0067
841 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 114 0.0067
842 ILLNESS 684 0.0066
843 BLOOD UREA INCREASED 111 0.0066
844 UPPER GASTROINTESTINAL HAEMORRHAGE 111 0.0066
845 ADVERSE DRUG REACTION 588 0.0065
846 INSURANCE ISSUE 100 0.0065
847 RASH 2850 0.0065
848 SWELLING 611 0.0065
849 STEVENS-JOHNSON SYNDROME 145 0.0065
850 PLEURAL EFFUSION 396 0.0065
851 RASH PRURITIC 352 0.0065
852 DRUG DOSE OMISSION 1071 0.0065
853 SKIN DISCOLOURATION 297 0.0065
854 EPISTAXIS 483 0.0065
855 PSORIATIC ARTHROPATHY 261 0.0064
856 CARDIAC DISORDER 600 0.0064
857 LUNG DISORDER 314 0.0064
858 METASTASES TO BONE 105 0.0064
859 MELAENA 140 0.0064
860 PERICARDIAL EFFUSION 146 0.0063
861 VISUAL ACUITY REDUCED 209 0.0063
862 THERAPY PARTIAL RESPONDER 98 0.0063
863 BLOOD POTASSIUM INCREASED 102 0.0063
864 DRUG RESISTANCE 161 0.0063
865 INTERSTITIAL LUNG DISEASE 302 0.0062
866 THROAT IRRITATION 277 0.0062
867 ISCHAEMIC STROKE 110 0.0062
868 URTICARIA 1029 0.0061
869 INTENTIONAL DOSE OMISSION 175 0.0061
870 DRUG DISPENSING ERROR 93 0.0061
871 ACUTE MYOCARDIAL INFARCTION 179 0.0061
872 PANCYTOPENIA 339 0.0061
873 JAUNDICE 163 0.0061
874 PNEUMOTHORAX 96 0.0060
875 HAEMOGLOBIN DECREASED 621 0.0060
876 BLISTER 339 0.0060
877 COVID-19 1059 0.0060
878 THERAPEUTIC RESPONSE DECREASED 365 0.0060
879 ERYTHEMA 1234 0.0060
880 WHITE BLOOD CELL COUNT DECREASED 649 0.0060
881 SNEEZING 134 0.0060
882 CEREBRAL HAEMORRHAGE 213 0.0059
883 PHARMACEUTICAL PRODUCT COMPLAINT 154 0.0059
884 CEREBROVASCULAR ACCIDENT 1004 0.0059
885 BLOOD CREATININE INCREASED 386 0.0059
886 SEPTIC SHOCK 254 0.0058
887 FEMUR FRACTURE 179 0.0058
888 STOMATITIS 350 0.0058
889 PRESCRIBED UNDERDOSE 115 0.0058
890 ILL-DEFINED DISORDER 349 0.0057
891 MYOCARDIAL INFARCTION 1001 0.0057
892 LIP SWELLING 191 0.0057
893 PNEUMONITIS 156 0.0057
894 LIVER DISORDER 252 0.0057
895 RASH GENERALISED 147 0.0057
896 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 403 0.0057
897 COLITIS ULCERATIVE 253 0.0057
898 GASTROINTESTINAL HAEMORRHAGE 470 0.0056
899 THROMBOSIS 450 0.0056
900 METRORRHAGIA 95 0.0056
901 SKIN CANCER 119 0.0055
902 THERAPEUTIC RESPONSE SHORTENED 183 0.0055
903 RENAL IMPAIRMENT 463 0.0055
904 EYE SWELLING 205 0.0055
905 MULTI-ORGAN FAILURE 95 0.0055
906 THERAPEUTIC PRODUCT EFFECT DECREASED 246 0.0055
907 RASH PAPULAR 123 0.0055
908 PRODUCT DOSE OMISSION IN ERROR 155 0.0055
909 HAEMOPTYSIS 152 0.0054
910 DERMATITIS 114 0.0054
911 NEUTROPHIL COUNT DECREASED 220 0.0054
912 RASH MACULAR 188 0.0054
913 RENAL DISORDER 250 0.0054
914 SYSTEMIC LUPUS ERYTHEMATOSUS 190 0.0053
915 PRODUCT PHYSICAL ISSUE 107 0.0053
916 ECZEMA 276 0.0053
917 SKIN FISSURES 103 0.0053
918 BLOOD BILIRUBIN INCREASED 142 0.0053
919 PRODUCT DOSE OMISSION 342 0.0052
920 CARDIOVASCULAR DISORDER 132 0.0052
921 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 933 0.0052
922 CONJUNCTIVITIS 96 0.0052
923 VAGINAL HAEMORRHAGE 220 0.0051
924 OSTEONECROSIS 166 0.0050
925 BLOOD GLUCOSE DECREASED 242 0.0050
926 LIVER FUNCTION TEST INCREASED 107 0.0050
927 LACRIMATION INCREASED 150 0.0050
928 PROCEDURAL PAIN 134 0.0048
929 HEPATIC FUNCTION ABNORMAL 177 0.0047
930 HAEMORRHAGE 494 0.0047
931 INJECTION SITE MASS 174 0.0047
932 PRODUCT DOSE OMISSION ISSUE 1363 0.0046
933 TASTE DISORDER 94 0.0046
934 NEEDLE ISSUE 133 0.0046
935 HYPOACUSIS 193 0.0045
936 GLYCOSYLATED HAEMOGLOBIN INCREASED 112 0.0044
937 BREAST CANCER FEMALE 118 0.0044
938 ANAPHYLACTIC REACTION 242 0.0044
939 LABORATORY TEST ABNORMAL 129 0.0044
940 NEUTROPENIA 594 0.0044
941 ANAPHYLACTIC SHOCK 112 0.0043
942 PRODUCT AVAILABILITY ISSUE 97 0.0043
943 LUNG NEOPLASM MALIGNANT 175 0.0043
944 BLOOD GLUCOSE INCREASED 799 0.0042
945 DRUG ADMINISTRATION ERROR 129 0.0042
946 SKIN EXFOLIATION 354 0.0042
947 PLATELET COUNT DECREASED 446 0.0042
948 FEBRILE NEUTROPENIA 273 0.0041
949 ACNE 311 0.0041
950 PRODUCT QUALITY ISSUE 552 0.0041
951 PAIN OF SKIN 109 0.0040
952 ADVERSE EVENT 373 0.0040
953 UNDERDOSE 295 0.0040
954 BREAST CANCER 374 0.0040
955 MENSTRUATION IRREGULAR 106 0.0040
956 INCORRECT DOSE ADMINISTERED 897 0.0039
957 INJECTION SITE PRURITUS 261 0.0039
958 OCULAR HYPERAEMIA 180 0.0038
959 INJECTION SITE URTICARIA 93 0.0038
960 INJECTION SITE REACTION 258 0.0037
961 INJECTION SITE BRUISING 299 0.0037
962 THERAPY INTERRUPTED 266 0.0037
963 EYE IRRITATION 214 0.0037
964 NEOPLASM PROGRESSION 123 0.0035
965 DISEASE PROGRESSION 410 0.0035
966 HOSPITALISATION 532 0.0035
967 BONE DENSITY DECREASED 108 0.0034
968 NEOPLASM MALIGNANT 230 0.0034
969 INJECTION SITE SWELLING 264 0.0034
970 DRY SKIN 456 0.0034
971 PRODUCT ADHESION ISSUE 122 0.0034
972 DEVICE DISLOCATION 146 0.0034
973 INJECTION SITE ERYTHEMA 416 0.0034
974 INJECTION SITE PAIN 995 0.0032
975 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 656 0.0032
976 EYE PRURITUS 107 0.0032
977 DEATH 2713 0.0031
978 MALIGNANT NEOPLASM PROGRESSION 307 0.0030
979 EXPIRED PRODUCT ADMINISTERED 98 0.0029
980 DEPENDENCE 156 0.0028
981 DEVICE ISSUE 254 0.0028
982 DEVICE BREAKAGE 114 0.0028
983 PLASMA CELL MYELOMA 108 0.0028
984 DERMATITIS ATOPIC 141 0.0027
985 INJECTION SITE HAEMORRHAGE 213 0.0027
986 SKIN BURNING SENSATION 181 0.0025
987 EXTRA DOSE ADMINISTERED 101 0.0025
988 SKIN IRRITATION 97 0.0021
989 DEVICE MALFUNCTION 142 0.0020
990 NO ADVERSE EVENT 302 0.0017
991 DEVICE EXPULSION 99 0.0015
992 ACCIDENTAL EXPOSURE TO PRODUCT 149 0.0014